Fertility and Sterility
Volume 91, Issue 2 , Pages 644-646, February 2009

Premature ovarian failure and dehydroepiandrosterone

  • Leonidas Mamas, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Leonidas Mamas M.D., Ph.D., Neogenesis IVF Centre, 3 Kifisias Ave, 151 23 Marousi, Athens, Greece (FAX: 30-210-6836090).
    • ,
  • Eudoxia Mamas, B.Sc.

Neogenesis IVF Centre, Athens, Greece

Received 15 October 2007; received in revised form 18 November 2007; accepted 19 November 2007. published online 05 March 2008.

Since the first successful birth at our center following treatment with DHEA in a patient with premature ovarian failure (POF), all subsequent patients with POF underwent the same treatment protocol. Receiving very encouraging results (FSH level was decreased in the first five patients and all achieved pregnancy), it was decided to study the action of DHEA for a reasonable length of time and in a larger number of patients to confirm the effectiveness of this particular therapeutic regime.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0015-0282(07)04120-9

doi:10.1016/j.fertnstert.2007.11.055

Fertility and Sterility
Volume 91, Issue 2 , Pages 644-646, February 2009

Article Tools